Mick Farrell, CEO of ResMed (RMD), joins Trading 360 to discuss their latest earnings and their work in respiratory medicine. It was a “very solid quarter,” he emphasizes, walking viewers through the key drivers, including in their supply chain. ResMed sells CPAP machines and sleep apnea treatments, and they are focusing on selling directly to the home. Mick also explains how they are expanding their distribution centers and manufacturing capacity in the U.S.